Metamark Genetics Completes $13M Series B Round as President and CEO Resigns | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Metamark Genetics has closed on a $13 million Series B financing round, while also announcing today the resignation of its President and CEO.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.